tiprankstipranks
Trending News
More News >
Advertisement

OSCV - ETF AI Analysis

Compare

Top Page

OSCV

Opus Small Cap Value ETF (OSCV)

Rating:67Neutral
Price Target:
$39.00
The Opus Small Cap Value ETF (OSCV) demonstrates solid potential, driven by strong holdings like The Ensign Group (ENSG) and Curtiss-Wright (CW), which contribute positively through robust financial performance, strategic growth, and stable outlooks. However, weaker technical indicators and valuation concerns in holdings such as Encompass Health (EHC) and Texas Roadhouse (TXRH) may have slightly tempered the overall rating. The ETF's concentration in small-cap stocks could pose risks due to potential volatility in this segment.
Positive Factors
Strong Top Holdings
Several top positions, such as Primoris Services and Curtiss-Wright, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Financials, Industrials, and Health Care, reducing reliance on any single industry.
Healthy Asset Growth
The fund has accumulated significant assets under management, indicating investor confidence and stability.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, with limited exposure to international markets, increasing vulnerability to domestic economic risks.
Mixed Holding Performance
Some holdings, such as Texas Roadhouse and Viper Energy, have underperformed year-to-date, potentially dragging on overall returns.
Higher Expense Ratio
The ETF's expense ratio is relatively high compared to other funds, which could eat into investor returns over time.

OSCV vs. SPDR S&P 500 ETF (SPY)

OSCV Summary

The Opus Small Cap Value ETF (Ticker: OSCV) focuses on small-cap companies, which are smaller businesses with market values between $300 million and $2 billion. It invests in value stocks, meaning companies that appear undervalued based on financial metrics like earnings and sales. Some of its top holdings include The Ensign Group and Curtiss-Wright. This ETF is ideal for investors looking to diversify their portfolios and tap into the growth potential of smaller, often overlooked companies. However, new investors should be aware that small-cap stocks can be more volatile, meaning their prices can rise and fall quickly.
How much will it cost me?The Opus Small Cap Value ETF (Ticker: OSCV) has an expense ratio of 0.79%, meaning you’ll pay $7.90 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on selecting undervalued small-cap stocks rather than tracking a broad index.
What would affect this ETF?The Opus Small Cap Value ETF (OSCV) could benefit from a strong U.S. economy, as small-cap companies often thrive during periods of economic growth and increased consumer spending. However, rising interest rates or economic uncertainty may negatively impact small-cap stocks, which tend to be more sensitive to market volatility. Additionally, sector-specific trends, such as changes in financial regulations or shifts in energy prices, could influence the ETF's performance given its sector exposures.

OSCV Top 10 Holdings

The Opus Small Cap Value ETF is leaning heavily on financials and industrials, which together make up a significant portion of its portfolio. American Healthcare REIT is a standout performer, rising steadily thanks to strong earnings and bullish sentiment, while Curtiss-Wright also adds momentum with robust growth potential. On the flip side, Texas Roadhouse and Viper Energy are dragging the fund, with inflationary pressures and bearish trends weighing on their performance. With its focus on U.S. small-cap value stocks, the ETF offers a concentrated bet on undervalued companies, though sector-specific risks remain a factor.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
4.30%$28.04M
The Ensign Group2.95%$19.24M$10.69B27.12%
78
Outperform
Curtiss-Wright2.79%$18.24M$20.15B47.11%
78
Outperform
Texas Roadhouse2.61%$17.06M$11.29B-15.54%
74
Outperform
Hanover Insurance2.55%$16.64M$6.56B13.90%
77
Outperform
American Healthcare REIT, Inc.2.47%$16.09M$9.15B68.51%
68
Neutral
Primoris Services2.46%$16.03M$6.68B47.19%
71
Outperform
Viper Energy2.42%$15.80M$13.04B-33.06%
69
Neutral
Encompass Health2.27%$14.83M$11.38B10.91%
62
Neutral
Primerica2.12%$13.87M$8.24B-14.92%
76
Outperform

OSCV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
37.47
Negative
100DMA
37.35
Negative
200DMA
36.15
Positive
Market Momentum
MACD
-0.23
Negative
RSI
49.73
Neutral
STOCH
55.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OSCV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.92, equal to the 50-day MA of 37.47, and equal to the 200-day MA of 36.15, indicating a neutral trend. The MACD of -0.23 indicates Negative momentum. The RSI at 49.73 is Neutral, neither overbought nor oversold. The STOCH value of 55.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OSCV.

OSCV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$639.18M0.79%
67
Neutral
$960.35M0.15%
72
Outperform
$338.11M0.55%
68
Neutral
$244.53M0.30%
69
Neutral
$119.30M0.70%
72
Outperform
$103.31M0.52%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OSCV
Opus Small Cap Value ETF
37.02
-3.22
-8.00%
SEIV
SEI Enhanced U.S. Large Cap Value Factor ETF
SEIS
SEI Select Small Cap ETF
JSML
Janus Henderson Small Cap Growth Alpha ETF
SCDV
Bahl & Gaynor Small Cap Dividend ETF
SIXS
ETC 6 Meridian Small Cap Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement